Literature DB >> 657587

The complement profile in relation to the "reactor" state: a study in the immediate post-partum period.

L W Mak.   

Abstract

C56 (activated "reactor") could be generated by adding zymosan to only nineteen out of the fifty serum samples obtained from southern Chinese women 3 to 5 days after a normal spontaneous delivery. As a group, post-partum sera showed a 25% increase in total haemolytic complement, an almost two-fold increase in haemolytic C5, C4 and C8 plus C9 activity, a 50% increase in antigenic C3 and haemolytic C2, C1 and factor B activity, a less than 20% increase in haemolytic C6 and C7 activity, and a 20% decrease in factor D and C1 inhibitor activity. Consequently, their C5:C7 ratios were significantly elevated. This finding supports, in part, the theory that the "reactor" state or ability to generate C56 depends on a relative excess of C56 over C7. However, comparison of the complement profile between sera with and those without "reactor" activity did not reveal any difference, except a greater elevation of C5 in the latter. It appears possible that a grossly excessive level of C5 may, in fact, be unfavourable to the generation of C56.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 657587      PMCID: PMC1541242     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  The alternate complement pathway in inflammatory bowel disease. Quantitation of the C3 proactivator (factor B) protein.

Authors:  P A Feinstein; S R Kaplan; W R Thayer
Journal:  Gastroenterology       Date:  1976-02       Impact factor: 22.682

2.  BETA-1-C-GLOBULIN: AN "ACUTE PHASE" SERUM REACTANT OF HUMAN SERUM.

Authors:  M HORNUNG; R C ARQUEMBOURG
Journal:  J Immunol       Date:  1965-02       Impact factor: 5.422

3.  Serologic tests for inflammation; serum complement, c-reactive protein and erythrocyte sedimentation rate in myocardial infarction.

Authors:  A J BOLTAX; E E FISCHEL
Journal:  Am J Med       Date:  1956-03       Impact factor: 4.965

4.  SEROLOGICAL STUDIES IN RHEUMATIC FEVER. II. SERUM COMPLEMENT IN THE RHEUMATIC STATE.

Authors:  E E Fischel; R H Pauli; J Lesh
Journal:  J Clin Invest       Date:  1949-09       Impact factor: 14.808

5.  C3 proactivator (C3PA) as an acute phase reactant.

Authors:  M Schutte; R DiCamelli; P Murphy; M Sadove; H Gewurz
Journal:  Clin Exp Immunol       Date:  1974-10       Impact factor: 4.330

6.  Acute phase proteins and C9 in patients with Behcet's syndrome and aphthous ulcers.

Authors:  M Adinolfi; T Lehner
Journal:  Clin Exp Immunol       Date:  1976-07       Impact factor: 4.330

7.  Serum inhibitor of C'1-esterase in health and disease.

Authors:  V H Donaldson
Journal:  J Lab Clin Med       Date:  1966-09

8.  [Elevated C3-proactivator serum levels in patients with chronic polyarthritis].

Authors:  B Stojan
Journal:  Z Rheumatol       Date:  1976 Jul-Aug       Impact factor: 1.372

9.  Effects of anesthesia, surgery and inflammation upon host defense mechanisms. I. Effects upon the complement system.

Authors:  M Schutte; R DiCamelli; P Murphy; M Sadove; H Gewurz
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

10.  Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9.

Authors:  P J Lachmann; R A Thompson
Journal:  J Exp Med       Date:  1970-04-01       Impact factor: 14.307

View more
  1 in total

1.  The acute phase response of C3, C5, ceruloplasmin, and C-reactive protein induced by turpentine pleurisy in the rabbit.

Authors:  P C Giclas; U Manthei; R C Strunk
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.